Moderna Jumps After Phase 3 Trial; Target Slides

English summary

U.S. stock futures edged lower in Asian trading on Wednesday, pointing to a cautious start on Wall Street after major indexes closed lower for a third consecutive session, as a global bond selloff and elevated oil prices kept investors wary and pressured rate-sensitive technology stocks. In premarket, Moderna jumped after Phase 3 trial, while Target slid.